Myfembree 40 MG-1 MG-0.5 MG TB 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FSVS0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,592
Award facts
- Contract value 100% obligated
- $4,591.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,591.99 to AmerisourceBergen Drug Corp for MYFEMBREE (40 mg/1 mg/0.5 mg tablets, 28-count package) on November 28, 2025, with completion scheduled for December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also the place of performance for this order—is a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The company maintains an extensive portfolio of federal contract awards predominantly with DLA and the Defense Health Agency, covering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for MYFEMBREE, a prescription hormone treatment product, is consistent with the company's demonstrated capability to fulfill federal medical supply requirements and serve military and veteran healthcare systems through its established federal contracting relationships.
Quick answers
Who was awarded contract SPE2DR26FSVS0?
SPE2DR26FSVS0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FSVS0 worth?
The government has obligated $4,592 on SPE2DR26FSVS0.
Is contract SPE2DR26FSVS0 an order under another contract?
Yes. SPE2DR26FSVS0 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSVS0 competed?
The extent of competition for SPE2DR26FSVS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award